Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-18-039176

Options or other derivatives

  • Director acquired 258,171 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Reynolds Donald Rogers Director 2018-06-20 Grant or award · Stock Option (Right to Buy) +258,171 258,171 D
Loading xslF345X03/doc4.xml…